Featured Research

from universities, journals, and other organizations

NIH Grant Allows UT Southwestern Researchers To Study Fast Biochemical Reactions

Date:
August 12, 1997
Source:
UT Southwestern Medical Center
Summary:
Imagine mixing tiny amounts of proteins and other biological molecules in a thousandth of a second and then studying the reactions that take place in a tenth of a second.

DALLAS ― August 12, 1997 ― Imagine mixing tiny amounts of proteins and other biological molecules in a thousandth of a second and then studying the reactions that take place in a tenth of a second. A National Institutes of Health (NIH) grant has enabled UT Southwestern Medical Center at Dallas researchers to purchase equipment that makes possible sensitive measurements of the fastest biological processes.

The NIH awarded a $180,000 Shared Equipment Grant to seven UT Southwestern investigators to obtain state-of-the-art rapid mixing and optical monitoring instruments, available to only a few medical centers in the country. The competitive funding is given to scientists who show they can make full use of a sophisticated and expensive laboratory instrument.

"No one of us could justify spending that kind of money to purchase this equipment for any individual project, but a shared facility of this kind is a wonderful asset to our research," said Dr. Elliott Ross, professor of pharmacology and holder of the Greer Garson and E.E. Fogelson Distinguished Chair in Medical Research.

"These instruments let us look at the rates and progress of fast biochemical reactions. By fast, I mean from less than one millisecond to five seconds. This means that we can study the details of how these reactions happen and the chemical nature of their intermediates. For instance, when a light flashes, how fast does the amplifying biochemistry in your retina record that information? How does it work? With this machine, you can actually determine the rates of those reactions," he said.

The instrument is based on four computer-controlled syringes. The syringes independently ― and very quickly ― mix reagents by injecting them into a series of three tiny mixing chambers, each only 15 microliters in volume (five ten-thousandths of an ounce). After mixing, the instrument can do two types of analyses. In the first, called stopped-flow, the reaction mixture is driven into a small quartz chamber, where several different optical techniques can be used to follow the course of the reaction. In the second, called quench-flow, the reaction is stopped at precise times, and the mixture is collected for chemical analysis.

The versatility of the new instrument is crucial for its shared use. Stopped-flow absorbance measurements -- looking at colored reaction intermediates -- can be used to follow complex enzyme reactions. Stopped-flow circular dichroism, which monitors molecular shape, can follow the rapid folding of a protein into its active conformation. Stopped-flow fluorescence can measure the binding of proteins to each other, changes in their structures and many other parameters. Quench-flow is used when no optical probe is available. To obtain such versatility, the UT Southwestern researchers worked with the manufacturer, BioLogic S.A., of Grenoble, France, to combine and adapt the necessary components. Specifications on the final order were six pages long and included several custom-designed items.

One UT Southwestern scientist sharing this machine, Dr. Margaret Phillips, assistant professor of pharmacology, will use it to study reactions catalyzed by several enzymes in trypanosomes, the parasites that cause sleeping sickness and Chagas' disease. Dr. Julian Peterson, professor of biochemistry, will use stop-flow spectroscopy to study the functions of P450s, a large class of enzymes that can degrade drugs, synthesize hormones and inactivate toxins. Dr. Philip Thomas, assistant professor of physiology, and Dr. Elizabeth Goldsmith, associate professor of biochemistry, will use circular dichroism to study how proteins fold and how regulators of enzyme action change the structure of their enzyme targets.

Ross and his group study signaling proteins that convey information from drug and neurotransmitter receptors to intracellular regulatory proteins. They will use quench-flow measurements to determine how stimulatory and inhibitory signals combine on the millisecond time scale to organize incoming signaling pathways.

"We are trying to measure these individual processes and how they are regulated," Ross said. "Determining the real turn-on and turn-off rates and what regulates the speed of these reactions has not really been done before.

"Where and when a response turns on and turns off is essential information. For instance, when you read, you are taking in a lot of light, but it's the cut-off between black and white that is important; when you hear a voice, the changes convey the information."

Ross said that stop-flow instruments have existed for 30 years, but previous ones were inefficient. They were too slow ― the fastest could not measure reactions faster than about 20 milliseconds ― and they required too much reagent, often 1,000 times more than is needed now.

"Five years ago, I wouldn't have dreamed of doing this kind of experiment because the equipment wasn't up to it," he said. "We couldn't possibly make enough enzyme or get enough sensitivity."

Other UT Southwestern researchers sharing in the grant are Dr. Joseph Albanesi, associate professor of pharmacology; Dr. James Stull, chairman of physiology and holder of the Fouad A. Bashour Chair in Physiology; and Dr. Clive Slaughter, associate professor of biochemistry and Howard Hughes Medical Institute investigator.

Ross said the researchers on the grant will have priority use of the equipment, but other NIH-funded UT Southwestern scientists will be able to use the instruments as well.

###

This news release is available on our World Wide Web home page at http://www.swmed.edu/news/newspubs.htm/


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "NIH Grant Allows UT Southwestern Researchers To Study Fast Biochemical Reactions." ScienceDaily. ScienceDaily, 12 August 1997. <www.sciencedaily.com/releases/1997/08/970812002257.htm>.
UT Southwestern Medical Center. (1997, August 12). NIH Grant Allows UT Southwestern Researchers To Study Fast Biochemical Reactions. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1997/08/970812002257.htm
UT Southwestern Medical Center. "NIH Grant Allows UT Southwestern Researchers To Study Fast Biochemical Reactions." ScienceDaily. www.sciencedaily.com/releases/1997/08/970812002257.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins